|
|
Title | Creator | Date |
1226 |
|
Thirteen-And-A-Half Syndrome | Daniel S. Allbon, MBChB, PGDipOphthBS; Ben La Hood, MBChB, PGDipOphthBS | 2016-06 |
1227 |
|
Posterior Reversible Encephalopathy Syndrome and Subarachnoid Hemorrhage After Lumboperitoneal Shunt for Fulminant Idiopathic Intracranial Hypertension | Anthony Fok, FRACP; Ronil V. Chandra, FRANZCR; Matthew Gutman, MBBS; Matthew Ligtermoet, MBBS; Udaya Seneviratne, FRACP; Peter Kempster, FRACP | 2016-06 |
1228 |
|
Orbital Apex Syndrome Secondary to Herpes Zoster Ophthalmicus | Florent Verhaeghe, MD; Max Villain, MD, PhD; Pierre Labauge, MD, PhD; Vincent Daien, MD, PhD | 2016-06 |
1229 |
|
Primary Central Nervous System Vasculitis With Optic Nerve Involvement | Christy E. Benson, MD; Alexander Knezevic, MD; Shannon C. Lynch, MD | 2016-06 |
1230 |
|
Reversible Cerebral Vasoconstriction Syndrome Presenting With Visual Field Defects | Meisha L. Raven, DO; Alexander L. Ringeisen, MD; Angela R. McAllister, MD; Daniel W. Knoch, MD | 2016-06 |
1231 |
|
Visual Deterioration and Herniation of the Anterior Cerebral Artery: Unusual Presentation of an Empty Sella Syndrome Complicating Decompression of a Rathke Cleft Cyst | Laxminadh Sivaraju, MCh; Sumit Thakar, Mch; Alangar S. Hegde, MCh, PhD | 2016-06 |
1232 |
|
The 8th Asian Neuro-Ophthalmology Society Congress | Byron L. Lam, MD; Xiaojun Zhang, MD, PhD | 2016-06 |
1233 |
|
Acknowledgment of Reviewers | | 2016-06 |
1234 |
|
Optic Neuropathy due to Chronic Lymphocytic Leukemia Proven With Optic Nerve Sheath Biopsy and Chronic Myelogenous Leukemia Relapse Presenting With Central Nervous System Blast Crisis and Bilateral Optic Nerve Infiltration: Comment | Michael S. Vaphiades, DO; Lina Nagia, DO; Elizabeth B. Keeble, MD; Glenn H. Roberson, MD | 2016-06 |
1235 |
|
Optic Atrophy in a Patient With Atypical Pantothenate Kinase-Associated Neurodegeneration | Jinu Han, MD; Do Wook Kim, MD; Chul-Ho Lee, BS; Sueng-Han Han, MD | 2016-06 |
1236 |
|
Preferential Ganglion Cell Loss in the Nasal Hemiretina in Patients With Pituitary Tumor | Ah Reum Jeong, MD; Eun-Young Kim, MD, PhD; Na Rae Kim, MD, PhD | 2016-06 |
1237 |
|
Acetazolamide-Induced Nephrolithiasis in Idiopathic Intracranial Hypertension Patients | Johnathan N. Au, MPH; Carin S. Waslo, MPH; Gerald McGwin Jr, PhD; Carrie Huisingh, MPH; Emanuel Tanne, MD | 2016-06 |
1238 |
|
Retinal Ganglion Cell Loss Precedes Retinal Nerve Fiber Thinning in Nonarteritic Anterior Ischemic Optic Neuropathy | Mohammadreza Akbari, MD; Parisa Abdi, MD; Masoud Aghsaei Fard, MD, FICO; Marjan Afzali, MD; Ahmad Ameri, MD; Alireza Yazdani-Abyaneh, MD; Massod Mohammadi, MD; Sasan Moghimi, MD | 2016-06 |
1239 |
|
Visual, Ocular Motor, and Cochleo-Vestibular Loss in Patients With Heteroplasmic, Maternally-Inherited Diabetes Mellitus and Deafness (MIDD), 3243 Transfer RNA Mutation | Simon Cardenas-Robledo, MD; Ali Saber Tehrani, MD; Gregory Blume, MD; Jorge C. Kattah, MD | 2016-06 |
1240 |
|
The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension | Samuel Bidot, MD; Lindsay Clough, BA; Amit M. Saindane, MD; Nancy J. Newman, MD; Valérie Biousse, MD; Beau B. Bruce, MD, PhD | 2016-06 |
1241 |
|
Nutritional Optic Neuropathy Caused by Copper Deficiency After Bariatric Surgery | Yuna Rapoport, MD, MPH; Patrick J. M. Lavin, MD | 2016-06 |
1242 |
|
Prevalence of Diabetic Retinopathy in a Population of Diabetics From the Middle East With Microvascular Ocular Motor Palsies | Alberto Gálvez-Ruiz, PhD; Patrik Schatz, MD, PhD | 2016-06 |
1243 |
|
Apical Orbital Aspergillosis Complicating Giant Cell Arteritis | Yang Zhou, BA; Michael L. Morgan, MD, PhD; Sumayya J. Almarzouqi; Patricia Chevez-Barrios; Andrew G. Lee, MD | 2016-06 |
1244 |
|
Literature Commentary | Mark L. Moster, MD; M. Tariq Bhatti, MD | 2016-06 |
1245 |
|
Are Erectile Dysfunction Medications Causally Related to Nonarteritic Anterior Ischemic Optic Neuropathy? | Michael S. Lee, MD; Michael Vaphiades, DO | 2016-06 |
1246 |
|
Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System | Howard D. Pomeranz, MD, PhD | 2016-06 |
1247 |
|
The 14th Hoyt Lecture: Ischemic Optic Neuropathy: The Evolving Profile, 1966-2015 | Anthony C. Arnold, MD | 2016-06 |
1248 |
|
A General Decline in Cerebrospinal Fluid Flow: An Overlooked Risk Factor for Glaucoma?: Response | Timothy J. McCulley, MD; Jessica R. Chang, MD | 2016-06 |
1249 |
|
The 42nd Annual Meeting of the North American Neuro-Ophthalmology Society | Kathleen B. Digre, MD | 2016-06 |
1250 |
|
Diagnostic Algorithm for Patients With Suspected Giant Cell Arteritis: Comment | Sohan S. Hayreh, MD, MS, PhD, DSc, FRCS, FRCOphth (Hon) | 2016-06 |